High dosage of cannabidiol (CBD) alleviates pentylenetetrazole-induced epilepsy in rats by exerting an anticonvulsive effect

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 6, 2015, Pages 8820-8827

  Mao, Ke ^a   You, Chao ^a   Lei, Ding ^a   Zhang, Heng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anticonvulsive; Astrocyte hyperplasia; Chronic epilepsy; Hippocampus; Pentylenetetrazole

Indexed keywords

CANNABIDIOL; GLIAL FIBRILLARY ACIDIC PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PENTETRAZOLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; ASTROCYTE; CELL HYPERPLASIA; CONTROLLED STUDY; DRUG MEGADOSE; EPILEPSY; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; MALE; MYOCLONIC JERK; NERVE INJURY; NONHUMAN; PENTYLENETETRAZOLE-INDUCED EPILEPSY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIC;

RATTUS;

EID: 84938391148     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. [1] Beaumont A and Whittle IR. The pathogenesis of tumor associated epilepsy. Acta Neurochir (Wien) 2000; 142: 1-15.
2. [2] Govori V, Humolli I, Cepreganov M, Dedushaj I and Gjikolli B. Brain tumors and epilepsy. Acta Clin Croat 2010; 49: 133-8.
3. [3] Rosati A, Tomassini A, Pollo B, Ambrosi C, Schwarz A, Padovani A and Bonetti B. Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol 2009; 93: 395-400.
4. [4] Roux FX and Nataf F. Cerebral oligodendrogliomas in adults and children. Current data and perspectives. Neurochirurgie 2005; 51: 410-4.
5. [5] Guerrini R. Epilepsy in children. Lancet 2006; 367: 499-524.
6. [6] Mackay MT, Bicknell-Royle J, Nation J, Humphrey M, Harvey AS. The ketogenic diet in refractory childhood epilepsy. J Paediatr Child Health 2005; 41: 353-7.
7. [7] Scheuer ML and Pedley TA. The evaluation and treatment of seizures. New Engl J Med 1990; 323: 1468-74.
8. [8] Löscher W and Schmidt D. New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 2006; 69: 183-272.
9. [9] Smith M, Wilcox KS and White HS. Discovery of antiepileptic drugs. Neurotherapeutics 2007; 4: 12-7.
10. [10] Chauhan AK, Dobhal MP and Joshi BC. A review of medicinal plants showing anticonvulsant activity. J Ethnopharmacol 1988; 22: 11-23.
11. [11] Nsour WN, Lau CB and Wong IC. Review on phytotherapy in epilepsy. Seizure 2000; 9: 96-107.
12. [12] Karler R, Cely W and Turkanis SA. The anticonvulsant activity of cannabidiol and cannabinol. Life Sciences 1973; 13: 1527-31.
13. [13] Ferenczy L, Gracza L and Jakobey I. An antibacterial prepartum from hemp (Cannabis sativa L). Naturwissenschaften 1958; 45: 188.
14. [14] Demehri S, Homayoun H, Honar H, Riazi K, Vafaie K, Roushanzamir F, Dehpour AR. Agmatine exerts anticonvulsant effect in mice: modulation by α2-adrenoceptors and nitric oxide. Neuropharmacology 2003; 45: 534-42.
15. [15] Su RB, Wei XL, Zheng JQ, Liu Y, Lu XQ and Li J. Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav 2004; 77: 345-9.
16. [16] Feng Y, LeBlanc MH and Regunathan S. Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci Lett 2005; 390: 129-33.
17. [17] Luszczki JJ, Czernecki R, Wojtal K, Borowicz KK and Czuczwar SJ. Agmatine enhances the anticonvulsant action of Phenobarbital and valproate in the mouse maximal electroshock seizure model. J Neural Transm 2008; 115: 1485-94.
18. [18] Bahremand A, Ziai P, Khodadad TK, Payandemehr B, Rahimian R, Ghasemi A, Ghasemi M, Hedayat T, Dehpour AR. Agmatine enhances the anticonvulsant effect of lithium chloride on pentylenetetrazole-induced seizures in mice: Involvement of L-arginine/nitricoxide pathway. Epilepsy Behav 2010; 18: 186-92.
19. [19] Stringer JL. Repeated seizures increase GFAP and vimentin in the hippocampus. Brain Res 1996; 717: 147-53.
20. [20] Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E and Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008; 29: 142-60.
21. [21] Ekonomou A and Angelatou F. Upregulation of NMDA receptors in hippocampus and cortex in the pentylenetetrazol-induced ‘kindling’ model of epilepsy. Neurochem Res 1999; 24: 1515-22.
22. [22] Bengzon J, Kokaia Z, Elmér E, Nanobashvili A, Kokaia M and Lindvall O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 1997; 94: 10432-7.
23. [23] Oses JP, Leke R, Portela LV, Lara DR, Schmidt AP, Casali EA, Wofchuk S, Souza DO, Sarkis JJ. Biochemical brain markers and purinergic parameters in rat CSF after seizure induced by pentylenetetrazol. Brain Res Bull 2004; 64: 237-42.